- Open Access
CDX2 hox gene product in a rat model of esophageal cancer
- Giuseppe Ingravallo†1, 2,
- Luigi Dall'Olmo†3,
- Daniela Segat†4,
- Matteo Fassan1,
- Claudia Mescoli1,
- Emanuela Dazzo4,
- Carlo Castoro3,
- Lorenzo Polimeno5,
- Christian Rizzetto6,
- Maurizio David Baroni4,
- Giovanni Zaninotto6, 7,
- Ermanno Ancona3, 6 and
- Massimo Rugge1, 3Email author
© Ingravallo et al; licensee BioMed Central Ltd. 2009
Received: 12 June 2009
Accepted: 7 August 2009
Published: 7 August 2009
Barrett's mucosa is the precursor of esophageal adenocarcinoma. The molecular mechanisms behind Barrett's carcinogenesis are largely unknown. Experimental models of longstanding esophageal reflux of duodenal-gastric contents may provide important information on the biological sequence of the Barrett's oncogenesis.
The expression of CDX2 hox-gene product was assessed in a rat model of Barrett's carcinogenesis. Seventy-four rats underwent esophago-jejunostomy with gastric preservation. Excluding perisurgical deaths, the animals were sacrificed at various times after the surgical treatment (Group A: <10 weeks; Group B: 10–30 weeks; Group C: >30 weeks).
No Cdx2 expression was detected in either squamous epithelia of the proximal esophagus or squamous cell carcinomas. De novo Cdx2 expression was consistently documented in the proliferative zone of the squamous epithelium close to reflux ulcers (Group A: 68%; Group B: 64%; Group C: 80%), multilayered epithelium and intestinal metaplasia (Group A: 9%; Group B: 41%; Group C: 60%), and esophageal adenocarcinomas (Group B: 36%; Group C: 35%). A trend for increasing overall Cdx2 expression was documented during the course of the experiment (p = 0.001).
De novo expression of Cdx2 is an early event in the spectrum of the lesions induced by experimental gastro-esophageal reflux and should be considered as a key step in the morphogenesis of esophageal adenocarcinoma.
In the homeobox gene family, the caudal-related CDX2 gene encodes for an intestine-specific transcription factor involved in both cell turnover and intestinal differentiation . Nuclear immunostain for Cdx2 is restricted to the native intestinal epithelia and its de novo expression is considered as suitable marker of a newly achieved intestinal commitment [2, 3].
Barrett's esophagus (BE) is defined as replacement of the native esophageal squamous epithelium by columnar (intestinalized) mucosa [4–6]. Longstanding exposure of the squamous esophageal epithelium to gastric reflux is a primary risk factor for columnar metaplasia, which is consistently considered as precursor of esophageal adenocarcinoma (Ac) [7, 8].
Esophageal Ac is the final step in a sequence of phenotypic changes that include long-standing esophagitis, columnar cell metaplasia, and non-invasive neoplasia (NiN). The molecular derangements occurring in each of these phenotypic changes are largely unknown and they involve both genetic and chromosomal instability [9, 10]. More information on such molecular changes is crucial in any strategy of primary prevention of Barrett's Ac [11–14].
In humans, both practical and ethical limitations prevent any sequential exploration of the cascade of Barrett's Ac, so experimental models are used to characterize the biological alterations leading to neoplastic transformation [15–31].
In this experimental study, the expression of Cdx2 protein was tested over the whole spectrum of phenotypic lesions detected in a surgical murine model of esophago-gastroduodenal anastomosis (EGDA) resulting in longstanding esophageal reflux of gastro-duodenal contents [19, 21–24, 29].
Postoperatively, the animals had free access to water and food. No treatments with any known carcinogen were applied.
Ten of the 74 rats died (mainly of respiratory complications) within 7 days after surgery and were not considered. As in already published experimental models, the animals were sacrificed at different times after surgery (i.e. Group A [22 rats] after <10 weeks [range = 3–9.9], Group B [22 rats] after 10–30 weeks [range = 10–29.7], and Group C [20 rats] after >30 weeks [range = 31–54]) [19, 21, 22, 27, 28].
This study was approved by the Institutional Animal Care Committee of the University of Padova. All procedures were performed in accordance to the Italian law on the use of experimental animals (DL n. 116/92 art. 5) and according to the "Guidelines on the Care and Use of Laboratory Animals" (NIH publication 85–93, revised in 1985).
Immediately after death, the thoracic and abdominal cavities were examined and the esophagus, stomach, and jejunum were excised en bloc. The esophagus was opened longitudinally through the dorsal wall. With the mucosal surface uppermost, the margins of the specimen were fixed to a cork plate with pins. Gross specimens were fixed in 10% neutral-buffered formalin for 24 hours. All specimens were examined grossly (see gross pathology) and cut serially (2–3 mm thick coronal sections). The tissue samples were routinely processed. Tissue sections 4 μm thick were obtained from paraffin blocks and stained with Haematoxylin & eosin. Lung, liver, kidney and spleen tissues were also collected for histological assessment. Two experienced gastrointestinal pathologists (GI & MF) reviewed all the slides.
Histological findings and Cdx2 expression in the rat model of esophageal carcinogenesis.
Group A (<10 weeks, n = 22)
Group B (10–30 weeks, n = 22)
Group C (>30 weeks, n = 20)
Non-ulcerative esophagitis was defined as sub-epithelial inflammatory infiltrate, generally coexisting with intraepithelial leukocytes; epithelial micro-erosions were arbitrarily included in this category.
Ulcers (defined as the complete loss of the mucosal layer with muscle exposure) always coexisted with granulation tissue and hyperplastic-regenerative changes of the surrounding epithelium.
Hyperplastic lesions were defined as thickening of the squamous epithelium (sometimes hyperkeratotic) with no cellular atypia. Regenerative lesions were assessed in terms of the increased length of the papillae in the lamina propria (>70% of mucosal thickness), also coexisting with hyperplasia of the proliferative compartment (>20% of the mucosal thickness) [16, 18, 25].
Metaplastic intestinalization was defined as the presence of both columnar epithelia and goblet cells [16, 18, 25]. Multilayered epithelium (MLE) is a hybrid epithelium in which both squamous and columnar epithelia coexist ("protometaplasia"); consistently with its phenotype, MLE expresses cytokeratins of both squamous and columnar differentiation .
Cancers were distinguished according to their histotype. Squamous cell carcinoma consisted in a neoplastic growth of squamous epithelia with different grades of differentiation. Adenocarcinoma consisted of atypical tubular/cystic glands with abundant extra-cellular mucins (Figure 1). Consistently with previous studies [18, 27, 29], we did not consider an autonomous group of "atypical" epithelial lesions. In fact, such phenotypical alterations are inconsistently described by the current international literature and their negligible prevalence in our study represents the rationale of including them among non-cancer lesions.
Cdx2 immunostain (anti-mouse-Cdx2 antibody, dilution 1:10; BioGenex Laboratories Inc., San Ramon, CA) was applied on 4-μm tissue sections. In all cases, a standardized ABC method was used, implemented on the Ventana Benchmark XT system (Touchstone, AZ). Appropriate positive (mouse colon) and negative (mouse spleen) controls were always run concurrently.
Cdx2 IHC expression was assessed negative (no immunostaining or sparse Cdx2-stained nuclei in less than 5% of the cells) or positive (nuclear immunoreaction in 5% or more of the cells).
Differences seen during the course of the experiment in terms of the incidence of pre-neoplastic/neoplastic lesions and/or overall Cdx2 staining (defined as the percentage of Cdx2-positive cases amongst the different histological categories) were evaluated using the modified Kruskal-Wallis non-parametric test for trend.
Differences were considered statistically significant when p < 0.05. All statistical analyses were performed with STATA software (Stata Corporation, College Station, Texas).
Pathology (gross and histology)
Three main types of gross lesion were encountered, i.e. reddened flat mucosa (at both gastric and esophageal sites), ulcers, and protruding and/or nodular lesions. The red mucosa was seen in the esophagus proximal to the EGDA (proximal stomach and distal esophagus), whereas both ulcers and protruding and/or nodular lesions were always located close to the anastomosis. All gross abnormalities were sampled for histological assessment.
The histological lesions detected in the 3 groups of animals are summarized in Table 1 and Figure 1. All rats had reflux (erosive or non-erosive) esophagitis proximal to the anastomosis. Mucosal ulcers were located in the middle/lower thirds of the esophagus in 15/22 (68.2%) animals in Group A; 14/22 (63.6%) in Group B and 6/20 (30%) in Group C. Regenerative/hyperplastic changes were also identified (Group A = 10/22 [45.5%]; Group B = 8/22 [36.4%], Group C = 10/20 [50.0%]).
None of the animals in Group A revealed any intestinal metaplasia (IM) and only 2 cases of MLE were seen (9.1%; both located close to the EGDA). In Groups B and C, MLE and IM were consistently identified and their prevalence increased significantly with the time elapsing after the operation (and with a similar prevalence of IM and MLE): Group B = 9/22 (40.9%); Group C = 12/20 (60.0%) (test for trend, p = 0.001).
Esophageal cancers were only documented histologically more than 10 weeks after the operation (no cancers came to light in Group A). In Group B, there were 10 esophageal malignancies (45.5%; 8 esophageal Ac and 2 SSC); in Group C, 9 cases of cancer were detected (45.0%; 7 esophageal Ac and 2 SSC). Eight cases of esophageal Ac were located proximally to the cardia; both cases of SSC developed in the middle-cervical esophagus. No neoplastic vascular invasion or metastatic lesions (nodal or extranodal) coexisted with the invasive cancers.
The prevalence of Cdx2 nuclear expression in each of the histological categories considered is shown in Table 1 and Figure 2. Cdx2 was never expressed in native squamous epithelia (including any non-ulcerative esophagitis) in the upper third of the esophagus. Aberrant and inconsistent Cdx2 nuclear expression was seen in the proliferative compartment of the squamous mucosa, close to esophageal ulcers and/or hyperplastic lesions (Group A = 4/22 [18.2%]; Group B = 6/22 [27.3%]; Group C = 8/20 [40.0%]).
In Groups B and C, intestinal metaplasia, multilayered epithelium, and esophageal Ac all consistently showed Cdx2 expression (Cdx2+ve cases: IM = 21/21; MLE = 21/21; Esophageal Ac = 15/15). A trend towards higher levels of overall Cdx2 expression was documented during the course of the experiment (test for trend; p = 0.001). None of the 4 cases of SCC showed Cdx2 staining.
Gastro-esophageal reflux is generally considered the main promoter of esophageal columnar metaplasia and adenocarcinoma.
Cdx2 is a transcription factor that regulates the expression of differentiation-related molecules and it is specifically involved in intestinal cells commitment. Based on this rationale, Cdx2 immunohistochemical expression was explored in a rat model of EGDA.
As in previous studies, de novo Cdx2 expression was documented in the whole spectrum of phenotypic changes induced by experimental EGDA. The prevalence of Cdx2 expression increased significantly with time (i.e. the prevalence of IM and MLE was higher in Groups B and C than in Group A), suggesting a time-dependent relationship between the "chemical" injury and the severity of the lesions.
Cdx2 expression in full-blown metaplastic transformation was expected. This study, however, also showed that de novo Cdx2 expression is an early event among the morphological changes caused by the refluxate. The early deregulation of Cdx2 expression has already been demonstrated by Pera et al. , who described Cdx2 immunostaining in the basal cell layer close to esophageal ulcers 16 weeks after surgery. More recently, however, in a study using a similar EGDA model, Xiaoxin Chen et al.  considered Cdx2 over-expression as a late marker of the metaplastic cascade.
Our study provides evidence that "protometaplastic" changes (in both the squamous stem cell and MLE) could be revealed by Cdx2 immunostaining even before the IM becomes histologically assessable. It is worth noting that MLE (which can also be a feature of normal rat mucosa) might be considered as a "partially-committed" cell population, prone to a chimeric intestinal differentiation under critical conditions (such as those produced by EGDA). Such speculations might also apply to the staminal cells compartment of the native esophageal mucosa: in cultured esophageal epithelia, in fact, chemical injuries (acid and/or bile components) may result in Cdx2 promoter demethylation/activation . These hypotheses are further supported by the finding that no Cdx2 expression was detected in squamous epithelia (far from esophageal ulcers/metaplastic changes), nor in any of the 4 cases of SCC.
Together with Cdx2, also other intestine-specific transcription factors have been described as involved in Barrett's epithelium development [34–36]. In a similar rat model, Kazumori et al.  showed, that a de novo expression of Cdx1 (another member of the caudal-related homeobox gene family) significantly antecedes Cdx2 expression [35, 36]. Further studies are needed to investigate on the interplay of these two genes in the morphogenesis of Barrett's mucosa.
The SCC cases detected in this study prompts us to hypothesize that the environmental conditions resulting from EGDA may also result into the derangement of cell regulatory mechanisms involving both multilayered and squamous epithelia. Previous studies documented that several transcription factors (p63, among others) are over-expressed in squamous esophageal epithelia after EGDA. Such an observation could explain, at least in part, the high prevalence of SCC documented in this and other studies.
In conclusion, the Kumagai-Hattori model of esophago-gastroduodenal anastomosis (with gastric preservation) is an useful in vivo model of esophageal carcinogenesis. Both the stem cell compartment and the multilayered epithelium are early involved in the metaplastic intestinalization of the native esophageal mucosa.
The authors are grateful to Cristiano Lanza and Vanni Lazzarin for their technical assistance. This work has been partially supported by a "G. Berlucchi" Foundation grant.
- Chawengsaksophak K, de Graaff W, Rossant J, Deschamps J, Beck F: Cdx2 is essential for axial elongation in mouse development. PNAS. 2004, 101: 7641-7645. 10.1073/pnas.0401654101.View ArticleGoogle Scholar
- Groisman GM, Amar M, Meir A: Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Modern Pathol. 2004, 17: 1282-1288. 10.1038/modpathol.3800182.View ArticleGoogle Scholar
- Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG: The homeodomain protein CDX2 is an early marker of Barrett's esophagus. J Clin Pathol. 2004, 57: 1063-1068. 10.1136/jcp.2003.015727.View ArticleGoogle Scholar
- Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology. 2000, 119: 333-338. 10.1053/gast.2000.9302.View ArticleGoogle Scholar
- Jankowski JA, Provenzale D, Moayyedi P: Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology. 2002, 122: 588-590. 10.1053/gast.2002.31599.View ArticleGoogle Scholar
- Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macri' G, Fiocca R, Munizzi F, Filiberti R: Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol. 2003, 98: 1931-1939. 10.1111/j.1572-0241.2003.07666.x.View ArticleGoogle Scholar
- Barrett NR: Chronic peptic ulcer of the oesophagus and "oesophagitis". Br J Surg. 1950, 38: 175-182. 10.1002/bjs.18003815005.View ArticleGoogle Scholar
- Grassi A, Giannarelli D, Iacopini F, Iannetti A, Giovannelli L, Efrati C, Barberani F, Giovannone M, Tosoni M: Prevalence of intestinal metaplasia in the distal esophagus in patients endoscopically suspected for short Barrett's esophagus. J Exp Clin Cancer Res. 2006, 25: 297-302.Google Scholar
- Sampliner RE: Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002, 97: 1888-1895. 10.1111/j.1572-0241.2002.05910.x.View ArticleGoogle Scholar
- Fitzgerald RC: Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006, 55: 1810-1820. 10.1136/gut.2005.089144.View ArticleGoogle Scholar
- Enzinger PC, Mayer RJ: Esophageal cancer. NEJM. 2003, 349: 2241-2252. 10.1056/NEJMra035010.View ArticleGoogle Scholar
- Paulson TG, Reid BJ: Focus on Barrett's esophagus and esophageal adenocarcinoma. Cancer cell. 2004, 6: 11-16. 10.1016/j.ccr.2004.06.021.View ArticleGoogle Scholar
- Chaves P, Cruz C, Cardoso P, Suspiro A, Pereira AD, de Almeida JC, Leitao CN, Soares J: Enterocytic columnar non-goblet cells of Barrett's esophagus – an immunohistochemical demonstration of association with malignant evolution. J Exp Clin Cancer Res. 2003, 22: 273-278.Google Scholar
- Xie L, Song X, Yu J, Wei L, Song B, Wang X, Lv L: Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Exp Clin Cancer Res. 2009, 27: 68-10.1186/1756-9966-28-68.View ArticleGoogle Scholar
- Li Y, Martin RC: Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2007, 20: 372-378. 10.1111/j.1442-2050.2007.00713.x.View ArticleGoogle Scholar
- Su Y, Chen , Klein M, Fang M, Wang S, Yang CS, Goyal RK: Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest. 2004, 84: 753-765. 10.1038/labinvest.3700079.View ArticleGoogle Scholar
- Chen X, Qin R, Ma Y, Su Y, Yang CS, Glickman JN, Odze RD, Shaheen NJ: Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008, 8: 1-10.1186/1471-230X-8-1.View ArticleGoogle Scholar
- Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR: Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. 1998, 2: 260-268. 10.1016/S1091-255X(98)80021-8.View ArticleGoogle Scholar
- Kumagai H, Mukaisho K, Sugihara H, Bamba M, Miyashita T, Miwa K, Hattori T: Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model. Scand J Gastroenterol. 2003, 38: 687-692. 10.1080/00365520310003435.View ArticleGoogle Scholar
- Goldstein SR, Yang G, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS: Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis. 1997, 18: 2265-2270. 10.1093/carcin/18.11.2265.View ArticleGoogle Scholar
- Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I, Hattori T: Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer. 1996, 67: 267-274. 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6.View ArticleGoogle Scholar
- Miwa K, Segawa M, Takano Y, Matsumoto H, Sahara H, Yagi M, Miyazaki I, Hattori T: Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer. 1994, 70: 185-189.View ArticleGoogle Scholar
- Sato T, Miwa K, Sahara H, Segawa M, Hattori T: The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res. 2002, 22: 39-44.Google Scholar
- Nishijima K, Miwa K, Miyashita T, Kinami S, Ninomiya I, Fushida S, Fujimura T, Hattori T: Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg. 2004, 240: 57-67. 10.1097/01.sla.0000130850.31178.8c.View ArticleGoogle Scholar
- Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ: Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res. 2006, 135: 337-344. 10.1016/j.jss.2006.04.023.View ArticleGoogle Scholar
- Chen X, Ding YW, Yang G, Bondoc F, Lee MJ, Yang CS: Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis. 2000, 21: 257-263. 10.1093/carcin/21.2.257.View ArticleGoogle Scholar
- Pera M, Brito MJ, Pera M, Poulson R, Riera E, Grande L, Hanby A, Wright NA: Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis. 2000, 21: 1587-1591. 10.1093/carcin/21.8.1587.View ArticleGoogle Scholar
- Pera M, Pera M, de Bolos C, Brito MJ, Palacin A, Grande L, Cardesa A, Poulson R: Duodenal-content reflux into the esophagus leads to expression of Cdx2 and Muc2 in areas of squamous epithelium in rats. J Gastrointest Surg. 2007, 11: 869-874. 10.1007/s11605-007-0162-7.View ArticleGoogle Scholar
- Tatsuta T, Mukaisho KI, Sugihara H, Miwa K, Tani T, Hattori T: Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux. Dig Dis Sci. 2005, 50: 425-431. 10.1007/s10620-005-2452-9.View ArticleGoogle Scholar
- Chen Z, Yang G, Ding WY, Bondoc F, Curtis SK, Yang CS: An esophagogastroduodenal anastomosis model for esophageal adenocarcinoma in rats and enhancement by iron overload. Carcinogenesis. 1999, 20: 1801-1808. 10.1093/carcin/20.9.1801.View ArticleGoogle Scholar
- Clark GW, Smyrk TC, Mirvish SS, Anselmino M, Yamashita Y, Hinder RA, DeMeester TR, Birt DF: Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol. 1994, 1: 252-261. 10.1007/BF02303531.View ArticleGoogle Scholar
- Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD: Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol. 2001, 25: 569-578. 10.1097/00000478-200105000-00002.View ArticleGoogle Scholar
- Marchetti M, Caliot E, Pringault E: Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci. 2002, 116: 1429-1436. 10.1242/jcs.00338.View ArticleGoogle Scholar
- Wong NA, Wilding J, Bartlett S, Liu Y, Warren BF, Piris J, Maynard N, Marshall R, Bodmer W: CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci USA. 2005, 102: 7565-7570. 10.1073/pnas.0502031102.View ArticleGoogle Scholar
- Stairs DB, Nakagawa H, Klein-Szanto A, Mitchell SD, Silberg DG, Tobias JW, Lynch JP, Rustgi AK: Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. Plos ONE. 2008, 3: e3534-10.1371/journal.pone.0003534.View ArticleGoogle Scholar
- Kazumori H, Ishihara S, Kinoshita Y: Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut. 2009, 58: 620-628. 10.1136/gut.2008.152975.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.